Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × SHR-1701 × Clear all

NCT04624217 2024-01-11

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms